Sanofi and GSK take COVID-19 vaccine into Phase 3 study

Submitted by admin on May 27, 2021 - 11:59am

Source:

Biopharma Reporter

News Tags:

Headline:

snippet:

Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.

Search form